Iain dedicates most of his time to high technology patent issues. He conducts pre-suit investigations and IP due diligence investigations and provides freedom-to-operate and opinions relating to infringement and validity, as well as litigating patent infringement cases. Iain also drafts and negotiates patent licenses and develops patent procurement and patent prosecution strategies. He has practiced before the USPTO for over 25 years and has extensive experience preparing and prosecuting patent applications. He has also been involved in many post-grant procedures in front of the PTO. For the past several years, his work has been involved in telecommunications, including cellular base stations and antennas, distributed antenna systems, WiFi and RF systems and components, and fiber optical systems. He is also experienced in preparing opinions relating to and litigating pharmaceutical patents, and he is experienced in preparing and serving Hatch Waxman “Paragraph IV” notice letters and detailed statements, and has represented several generic pharmaceutical companies in several ANDA patent litigations.
Prior to becoming a patent attorney Iain spent several years as a professional physicist, working in different technologies such as lasers, optics, semiconductors, RF and radar systems, and pulsed power. He has patent experience in these areas, in addition to other technical fields such as LCD displays, medical devices, DNA sequencing, and biomedical assays.
In 2002, he was named by Minnesota Lawyer magazine as one of the Top 10 Up and Coming Attorneys in Minnesota.
EDUCATION
University of Minnesota
Master of Biological Sciences
William Mitchell College of Law
J.D. summa cum laude
University of St. Andrews, Scotland
Ph.D. Physics
University of Strathclyde, Scotland
B.Sc., Applied Physics, 1st class honors
BAR ADMISSIONS
Minnesota Supreme Court
U.S. District Court for the District of Minnesota
U.S. Court of Appeals for the Federal Circuit
U.S. Patent and Trademark Office
REPRESENTATIVE CASES
Elan Corporation v. Teva Pharmaceuticals USA, Inc. (dexmethylphenidate ER)
Elan v. Barr Pharmaceuticals (dexmethylphenidate ER)
Elan v. Teva Pharmaceuticals USA, Inc. (dexmethylphenidate ER)
Forest Labs, et al. v. Teva Pharmaceuticals USA, Inc., et al.(memantine extended-release)
Hoffmann-La Roche v. Teva Pharmaceuticals USA, Inc. (capecitabine)
Novartis AG, et al. v. Teva Pharmaceuticals USA, Inc., et al. (mycophenolic acid)
Pozen v. Teva Pharmaceuticals USA, Inc. (sumatriptan and naproxen sodium)